Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p57
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 57/66)
Character Range: 181452–187491

who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16096  P16096  CN16096  Posaconazole                 Fungal infection                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures
                                                      The condition must be fusariosis; or
                                                      The condition must be zygomycosis; or
                                                      The condition must be coccidioidomycosis; or
                                                      The condition must be chromoblastomycosis; or
                                                      The condition must be mycetoma; AND
                                                      Patient must be unable to tolerate alternative therapy; or
                                                      Patient must have disease refractory to alternative therapy; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16099  P16099  CN16099  Itraconazole                 Disseminated pulmonary histoplasmosis infection                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 16099
                                                      Treatment and maintenance therapy
                                                      Patient must be diagnosed with acquired immunodeficiency syndrome (AIDS); AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16101  P16101  CN16101  Itraconazole                 Chronic pulmonary histoplasmosis infection                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 16101
                                                      Treatment and maintenance therapy
                                                      Patient must be diagnosed with acquired immunodeficiency syndrome (AIDS); AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16102  P16102  CN16102  Itraconazole                 Oesophageal candidiasis                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 16102
                                                      Patient must be immunosuppressed; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16104  P16104  CN16104  Fremanezumab                 Treatment-resistant migraine                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures - Streamlined Authority Code 16104
                                                      Initial treatment
                                                      Must be treated by a neurologist; or
                                                      Must be treated by a general practitioner in consultation with a neurologist; AND
                                                      Patient must not be undergoing concurrent treatment with the following